Company / Capital Returned to Shareholders per Share
Chemed Corp. Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$32.03
FY2025
5-year range
$6.00 / $37.52
FY2021-FY2025
Trend
+25.2%
vs FY2024
Sector context
#4 of 108
Health Care
What the data says
Among 108 Health Care companies, Chemed Corp. is in the top 4% for capital returned to shareholders per share. Capital Returned to Shareholders per Share has fluctuated over the past 10 years, ranging from $6.00 in FY2023 to $37.52 in FY2021.
Based on SEC 10-K filings.
32.03 in FY2025 with a 5-year CAGR of +21.7%. Top quartile in the Health Care sector.
Improved from $6.00 to $32.03 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +52.4%
- 5-Year CAGR
- +21.7%
- 10-Year CAGR
- -
Sector benchmark
+531.6% above sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 25.2% year-over-year.
- Ranks #4 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2021.
- Lowest capital returned to shareholders per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.03 | +25.2% |
| FY2024 | $25.58 | +326.4% |
| FY2023 | $6.00 | -33.6% |
| FY2022 | $9.04 | -75.9% |
| FY2021 | $37.52 | +212.9% |
| FY2020 | $11.99 | +76.3% |
| FY2019 | $6.80 | -35.6% |
| FY2018 | $10.57 | +57.9% |
| FY2017 | $6.69 | -5.4% |
| FY2016 | $7.07 | +64.5% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026